GBA's "2021 Stock Phantasma"

stonedinvestor said:
A)Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler 12:22 JNCE, GILD Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating and $20 price target on Jounce Therapeutics (JNCE), which will receive a $25M milestone from partner Gilead (GILD) for IND clearance for anti-CCR8 antibody GS-1811. Jounce, which expects to initiate eight expansion cohorts in 2H21, now holds pro forma cash of roughly $296M to advance its innovative I-O pipeline, Tenthoff tells investors in a research note.

B)Clearside reported 'impressive' data in wet AMD, says Roth Capital 11:48 CLSD

(JNCE)$8.19<----// $8.45 HOD High volume

Clearside Biomedical, Inc. (CLSD) Imense vol

4.0661+1.0461 (+34.6391%)<----// HOD $4.79
As of 2:51PM EDT. Market open.

Clearside success with Xipere can derisk pipeline, says Roth Capital 06/02 CLSD, BHC After Clearside Biomedical (CLSD) and partner Bausch Health Companies (BHC) announced that the FDA has accepted the resubmitted New Drug Application for Xipere, Roth Capital analyst Zegbeh Jallah noted that progress had been slowed by manufacturing issues that resulted in a CRL. However, based on the NDA acceptance, the FDA's concerns have now been addressed, said Jallah, who is "clearly very bullish" on approval in October and a commercial launch in 2022. The analyst, who thinks approval of Xipere should derisk Clearside's SCS Microinjector and give Clearside some non-dilutive capital to advance its pipeline, keeps a Buy rating on the shares and identifies the stock as a 2021 top pick.
More...
Stoney!

I've been busy. I do like MQ. Read quite a bit of their S-1 earlier.
They have good margins. It's not really a payment service like SQ, its more of a behind the scenes thing. I like it. If it gets in the $27 range on a sell-off, it'll go in the G4G portfolio for the long haul.
I don't think it'll drop that low however, all things being equal.
 
It's not really a payment service like SQ,

EXACTLY!

DOES DAVID REPORT TOMORROW???

Davids Tea options imply 20.7% move in share price post-earnings 15:34 DTEA Pre-e
 
Alright lets talk Tile Shop.

On the negative side I managed to buy a retail stk on a day folks are suddenly questioning retail.

On the positive side there is ongoing drama with one big seller and he is sold out.
Mr Rucker.


Transaction Shares Price Range ($) Shares Held Mkt Value
6/3/21 Rucker Robert A
Unknown
x.gif
Sale 847,013 7.44 – 7.50 44,879 $6.3 M
6/1/21 Rucker Robert A
Unknown
x.gif
Sale 93,650 7.72 – 7.78 891,892 $725.5 K
5/26/21 Rucker Robert A
Unknown
x.gif
Sale 458,654 6.95 – 6.95 985,542 $3.2 M
5/21/21 Rucker Robert A
Unknown
x.gif
Sale 157,500 7.22 – 7.42 1,444,196 $1.1 M
5/12/21 Rucker Robert A
Unknown
x.gif
Sale 583,964 6.55 – 6.87 1,601,696 $3.9 M
5/10/21 Rucker Robert A
Unknown
x.gif
Sale 105,852 7.05 – 7.05 2,185,660 $746.3 K
5/5/21 Rucker Robert A
Unknown
x.gif
Sale 97,389 6.50 – 6.95 2,291,512 $674.3 K
5/3/21 Rucker Robert A
Unknown
x.gif
Sale 122,046 7.19 – 7.41 2,388,901 $899.5 K
4/29/21 Rucker Robert A
Unknown
x.gif
Sale 56,108 7.10 – 7.25 2,510,947 $401.1 K
4/27/21 Rucker Robert A
Unknown
x.gif
Sale 6,734 7.22 – 7.22 2,567,055 $48.6 K
4/20/21 Rucker Robert A
Unknown
x.gif
Sale 235,811 6.92 – 7.06 2,573,789 $1.6 M
 
You must log in or register to reply here.
Back
Top